SEC Form 4 · accession 0001179110-17-014170
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amy C. Peterson
Officer — CMO, Immuno-oncology
Period of report
Nov 13, 2017
Accepted (ET)
Nov 15, 2017 · 8:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| American Depositary SharesF1,F3 | Nov 13, 2017 | S | 2,400 | $82.7887 | D | 1,201 | D | |
| American Depositary SharesF1,F4 | Nov 13, 2017 | S | 1,201 | $83.3091 | D | 0 | D | |
| Ordinary Shares | holding | — | — | — | 225,002 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Each American Depositary Share represents 13 Ordinary Shares.
- F2The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.12 to $83.11, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.13 to $84.04, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.